Objective(s): To evaluate the “flow void” diameter in patients with pregnancy-related diseases with and without uterine AVMs and assess the diagnostic performance of unenhanced MRI for uterine AVMs.
Study Design: From May 2014 to April 2019, 79 patients with pregnancy-related diseases were included, including 36 with and 43 without uterine AVMs confirmed by DSA. On MRI, the diameter of the most prominent “flow void” (hereinafter referred to as fv-D) was measured and compared between patients with and without uterine AVMs. The diagnostic performance of fv-D was estimated with receiver operating characteristic curves.
Results: The “flow void” sign was observed in patients with and without uterine AVMs (P>0.05). The fv-D was significantly larger in patients with uterine AVMs in the myometrium and parametrium than in patients without uterine AVMs (P<0.0001). The fv-D achieved a reliable diagnostic performance in the myometrium (sensitivity: 80.56%, specificity: 60.27%, AUC: 0.727, cut-off:>1.33 mm) and parametrium (sensitivity: 97.22%, specificity: 67.44%, AUC: 0.881, cut-off:>2.6 mm).
Conclusions: On MRI, fv-D could diagnose uterine AVMs. The fv-D had a much higher diagnostic efficiency in the parametrium than in the myometrium. The parametrium fv-D greatly improved the diagnostic sensitivity and provides a more accurate, noninvasive method of investigating possible uterine AVMs.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5
No competing interests reported.
Loading...
Posted 17 May, 2021
On 27 Aug, 2021
Received 26 Aug, 2021
On 16 Aug, 2021
Received 28 Jun, 2021
On 28 Jun, 2021
Invitations sent on 18 Jun, 2021
On 18 Jun, 2021
On 13 May, 2021
On 12 May, 2021
On 11 May, 2021
Posted 17 May, 2021
On 27 Aug, 2021
Received 26 Aug, 2021
On 16 Aug, 2021
Received 28 Jun, 2021
On 28 Jun, 2021
Invitations sent on 18 Jun, 2021
On 18 Jun, 2021
On 13 May, 2021
On 12 May, 2021
On 11 May, 2021
Objective(s): To evaluate the “flow void” diameter in patients with pregnancy-related diseases with and without uterine AVMs and assess the diagnostic performance of unenhanced MRI for uterine AVMs.
Study Design: From May 2014 to April 2019, 79 patients with pregnancy-related diseases were included, including 36 with and 43 without uterine AVMs confirmed by DSA. On MRI, the diameter of the most prominent “flow void” (hereinafter referred to as fv-D) was measured and compared between patients with and without uterine AVMs. The diagnostic performance of fv-D was estimated with receiver operating characteristic curves.
Results: The “flow void” sign was observed in patients with and without uterine AVMs (P>0.05). The fv-D was significantly larger in patients with uterine AVMs in the myometrium and parametrium than in patients without uterine AVMs (P<0.0001). The fv-D achieved a reliable diagnostic performance in the myometrium (sensitivity: 80.56%, specificity: 60.27%, AUC: 0.727, cut-off:>1.33 mm) and parametrium (sensitivity: 97.22%, specificity: 67.44%, AUC: 0.881, cut-off:>2.6 mm).
Conclusions: On MRI, fv-D could diagnose uterine AVMs. The fv-D had a much higher diagnostic efficiency in the parametrium than in the myometrium. The parametrium fv-D greatly improved the diagnostic sensitivity and provides a more accurate, noninvasive method of investigating possible uterine AVMs.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5
No competing interests reported.
Loading...